DNA methylation-based classification of hematolymphoid neoplasms
Annapurna Saksena, Christin Siewert, Rust Turakulov, Omkar Singh et autres
1 citationBlood Advances
Mark Raffeld
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
795Publications signalées
46390Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Lymphoma Diagnosis and TreatmentViral-associated cancers and disordersChronic Lymphocytic Leukemia ResearchCAR-T cell therapy researchLung Cancer Treatments and Mutations
Publications récentes
CNS tumor type prevalence according to age group: An analysis of 21 000 cases confirmed by methylation profiling, with a focus on adolescents and young adults
Adriana Fonseca, Leeor Yefet, Omkar Singh, Christopher H. Dampier et autres
0 citationsNeuro-Oncology
Case Report: Rare pheochromocytoma in a patient with Li–Fraumeni syndrome: a 3-event, 4-hit model of pathogenesis
Yi Liu, Aaron J Dinerman, Ina Lee, Liqiang Xi et autres
0 citationsFrontiers in Oncology
1262 Genomic landscape of Follicular Dendritic Cell Neoplasms and molecular differences in Follicular Dendritic Cell Sarcoma with and without hyaline vascular Castleman Disease
Annapurna Saksena, Rust Turakulov, J. F. Cheng, Manoj Tyagi et autres
0 citationsLaboratory Investigation
Intracranial mesenchymal tumor, FET::CREB fusion-positive: An integrative analysis of 81 cases
Sharika Rajan, Hye‐Jung Chung, Zhichao Wu, Omkar Singh et autres
3 citationsNeuro-Oncology
P092: Refining somatic variant classification: A single-institution evaluation of the 2022 ClinGen/CGC/VICC oncogenicity guidelines
Christina K. Ferrone, Yi Liu, Valerie Zgonc, Svetlana Pack et autres
0 citationsGenetics in Medicine Open
Supplementary Figure S4 from Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial
Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon et autres
0 citations
Supplementary Data S1 from Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial
Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon et autres
0 citations
Supplementary Figure S1 from Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial
Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon et autres
0 citations
Supplementary Table S2 from Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial
Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon et autres
0 citations
Supplementary Table S1 from Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial
Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon et autres
0 citations
Supplementary Figure S3 from Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial
Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer, Christophe E. Redon et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.